Medical Imaging

Physicians utilize medical imaging to see inside the body to diagnose and treat patients. This includes computed tomography (CT), magnetic resonance imaging (MRI), X-ray, ultrasound, fluoroscopy, angiography, and the nuclear imaging modalities of PET and SPECT.

Signs of Alzheimer's evident on imaging up to 15 years prior to symptom onset in Down syndrome population
By identifying these structural changes prior to the onset of symptomatic neurodegeneration, providers may be able to initiate preventive therapies sooner.
Bristol Myers Squibb will pay $350M-plus to add prostate cancer imaging agent
Subsidiary RayzeBio has inked a definitive deal to license the worldwide rights for the drug from Philochem, a Swiss biotechnology firm.
FDA issues recall of Philips interventional imaging system due to safety risks
A communication error within the system can reportedly cause loss of imaging functionality mid-procedure.
FDA-cleared software increases throughput for flurpiridaz back-to-back rest-stress imaging
The new F-18 flurpiridaz radiotracer is expected to help drive cardiac PET growth, but it requires waiting between rest and stress scans. Software from MultiFunctional Imaging can help care teams combat that problem.
A new payer tactic: Using AI to curtail routine radiology claims, after imaging is already delivered
“Unlike [prior authorization], this model does not delay patient care and does not hold members liable to pay for unneeded exams,” writes radiologist Mark Hiatt, MD, MBA.

Ga-68 DOTATATE PET/CT finds more NETs

A comparison study of three different methods of neuroendocrine tumor (NET) detection that includes PET/CT, SPECT/CT and whole body MR imaging places PET/CT with gallium-68 (Ga-68) DOTATATE on a pedestal above the rest for its sensitivity in finding NETs, according to a study published Aug. 28 in the Journal of Nuclear Medicine.

Stem Cells reveal neurochemical flood in schizophrenics

Schizophrenia may be tripped off by an overabundance of chemical signals pumped out by neurons in the brain. The University of California, San Diego, announced Sept. 11 that researchers from the Skaggs School of Pharmacy and Pharmaceutical Sciences are using stem cells to see the flood of neurotransmitters first-hand.

IBA and Philips to collaborate on cancer research and technology

Ion Beam Applications (IBA) announced today that the company will be teaming up with Philips Healthcare to develop new diagnostic and therapeutic research and technology, including proton therapy systems.

AAA acquires GE's FDG-PET sector in Italy

Advanced Accelerator Applications (AAA) announced today that it has acquired GE Healthcare’s FDG-PET radiopharmaceutical division in Italy.

NOPR: All NaF agreements must be updated

The American College of Radiology and the Medical Imaging and Technology Alliance are prompting all participants of the bone-imaging portion of the National Oncologic PET Registry (NOPR) to sign new agreements by Sept. 22.

Example of a RF burn from an MRI scan where a sedated patient's identification bracelet was touching their skin during an exam. Image courtesy of RSNA. https://pubs.rsna.org/doi/10.1148/radiol.09090637

Battling Burns in MRI

While MRI is often considered one of the safer imaging modalities due to its lack of ionizing radiation, other dangers remain for patients, with thermal burns being a chief concern.

NanoSomix to offer Alzheimer’s blood assay for research

A blood test that predicts a patient’s likelihood of developing Alzheimer’s disease has been the target of a multi-center National Institutes of Health study and was recently publicized by the Alzheimer’s Association. Aliso Viego, Calif., based NanoSomiX announced today that it would begin providing the assay to researchers and pharmaceutical companies studying Alzheimer’s treatments this fall.

Cutting SPECT MPI scan time in half

A novel reconstruction method of cardiac SPECT myocardial perfusion imaging (MPI) could potentially reduce scan times by 50 percent and cut 75 percent of the time it takes to reconstruct images, according to research announced by the University of Eastern Finland yesterday.

Medical Imaging

Signs of Alzheimer's evident on imaging up to 15 years prior to symptom onset in Down syndrome population

Bristol Myers Squibb will pay $350M-plus to add prostate cancer imaging agent

FDA issues recall of Philips interventional imaging system due to safety risks

FDA-cleared software increases throughput for flurpiridaz back-to-back rest-stress imaging

A new payer tactic: Using AI to curtail routine radiology claims, after imaging is already delivered